|
1
|
Hochachka PW: Mechanism and evolution of
hypoxia-tolerance in humans. J Exp Biol. 201:1243–1254.
1998.PubMed/NCBI
|
|
2
|
Vaupel P, Thews O and Hoeckel M: Treatment
resistance of solid tumors: role of hypoxia and anemia. Med Oncol.
18:243–259. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakayama K, Kanzaki A, Hata K, et al:
Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in
human ovarian carcinoma. Cancer Lett. 176:215–223. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kuwai T, Kitadai Y, Tanaka S, et al:
Expression of hypoxia-inducible factor-1alpha is associated with
tumor vascularization in human colorectal carcinoma. Int J Cancer.
105:176–181. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ioannou M, Mylonis I, Kouvaras E, et al:
Validated analysis of HIF-1α expression in cancer cells using a
controlled and comparative immunoassay. Oncol Rep. 24:161–169.
2010.
|
|
6
|
Wang GL, Jiang BH, Rue EA and Semenza GL:
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tension. Proc Natl
Acad Sci USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Salceda S and Caro J: Hypoxia-inducible
factor 1alpha (HIF-1alpha) protein is rapidly degraded by the
ubiquitin-proteasome system under normoxic conditions. Its
stabilization by hypoxia depends on redox-induced changes. J Biol
Chem. 272:22642–22647. 1997. View Article : Google Scholar
|
|
8
|
Wang GL and Semenza GL: General
involvement of hypoxia-inducible factor 1 in transcriptional
response to hypoxia. Proc Natl Acad Sci USA. 90:4304–4308. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Krieg M, Haas R, Brauch H, Acker T, Flamme
I and Plate KH: Up-regulation of hypoxia-inducible factors
HIF-1alpha and HIF-2alpha under normoxic conditions in renal
carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of
function. Oncogene. 19:5435–5443. 2000. View Article : Google Scholar
|
|
10
|
Iliopoulos O, Levy AP, Jiang C, Kaelin WG
Jr and Goldberg MA: Negative regulation of hypoxia-inducible genes
by the von Hippel-Lindau protein. Proc Natl Acad Sci USA.
93:10595–10599. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bianco F, Basini G, Santini S and
Grasselli F: Angiogenic activity of swine granulosa cells: effects
of hypoxia and the role of VEGF. Vet Res Commun. 29(Suppl 2):
157–159. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choi SB, Park JB, Song TJ and Choi SY:
Molecular mechanism of HIF-1-independent VEGF expression in a
hepatocellular carcinoma cell line. Int J Mol Med. 28:449–454.
2011.PubMed/NCBI
|
|
13
|
Yasuda S, Arii S, Mori A, et al:
Hexokinase II and VEGF expression in liver tumors: correlation with
hypoxia-inducible factor 1 alpha and its significance. J Hepatol.
40:117–123. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takahashi R, Tanaka S, Hiyama T, et al:
Hypoxia-inducible factor-1α expression and angiogenesis in
gastrointestinal stromal tumor of the stomach. Oncol Rep.
10:797–802. 2003.
|
|
15
|
Giatromanolaki A, Koukourakis MI, Sivridis
E, et al: Relation of hypoxia inducible factor 1 alpha and 2 alpha
in operable non-small cell lung cancer to angiogenic/molecular
profile of tumours and survival. Br J Cancer. 85:881–890. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Casiglia J and Woo SB: A comprehensive
review of oral cancer. Gen Dent. 49:72–82. 2001.
|
|
17
|
Wittekind C, Compton CC, Greene FL and
Sobin LH: TNM residual tumor classification revisited. Cancer.
94:2511–2516. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gordan JD and Simon MC: Hypoxia-inducible
factors: central regulators of the tumor phenotype. Curr Opin Genet
Dev. 17:71–77. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Semenza GL: Hypoxia, clonal selection, and
the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol.
35:71–103. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar
|
|
21
|
Richard DE, Berra E and Pouysségur J:
Angiogenesis: how a tumor adapts to hypoxia. Biochem Biophys Res
Commun. 266:718–722. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kyzas PA, Stefanou D, Batistatou A and
Agnantis NJ: Prognostic significance of VEGF immunohistochemical
expression and tumor angiogenesis in head and neck squamous cell
carcinoma. J Cancer Res Clin Oncol. 131:624–630. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vidal O, Soriano-Izquierdo A, Pera M, et
al: Positive VEGF immunostaining independently predicts poor
prognosis in curatively resected gastric cancer patients: results
of a study assessing a panel of angiogenic markers. J Gastrointest
Surg. 12:1005–1014. 2008. View Article : Google Scholar
|
|
24
|
Zhao ZQ, Yang S and Lu HS: Expression of
midkine and vascular endothelial growth factor in gastric cancer
and the association of high levels with poor prognosis and
survival. Mol Med Report. 5:415–419. 2012.PubMed/NCBI
|
|
25
|
Sugiura T, Inoue Y, Matsuki R, et al:
VEGF-C and VEGF-D expression is correlated with lymphatic vessel
density and lymph node metastasis in oral squamous cell carcinoma:
Implications for use as a prognostic marker. Int J Oncol.
34:673–680. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shibaji T, Nagao M, Ikeda N, et al:
Prognostic significance of HIF-1 alpha overexpression in human
pancreatic cancer. Anticancer Res. 23:4721–4727. 2003.PubMed/NCBI
|
|
27
|
Gruber G, Greiner RH, Hlushchuk R, et al:
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an
independent prognostic parameter? Breast Cancer Res. 6:R191–R198.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu XG, Xing CG, Feng YZ, Chen J and Deng
C: Clinical significance of immunohistochemical expression of
hypoxia-inducible factor-1alpha as a prognostic marker in rectal
adenocarcinoma. Clin Colorectal Cancer. 5:350–353. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Birner P, Schindl M, Obermair A, Plank C,
Breitenecker G and Oberhuber G: Overexpression of hypoxia-inducible
factor 1alpha is a marker for an unfavorable prognosis in
early-stage invasive cervical cancer. Cancer Res. 60:4693–4696.
2000.PubMed/NCBI
|
|
30
|
Bos R, van der Groep P, Greijer AE, et al:
Levels of hypoxia-inducible factor-1alpha independently predict
prognosis in patients with lymph node negative breast carcinoma.
Cancer. 97:1573–1581. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fillies T, Werkmeister R, van Diest PJ,
Brandt B, Joos U and Buerger H: HIF1-alpha overexpression indicates
a good prognosis in early stage squamous cell carcinomas of the
oral floor. BMC Cancer. 5:842005. View Article : Google Scholar : PubMed/NCBI
|
